June 2016-Global Lifesciences Business in India - News & Updates


Highlights for June 2016:

  1. Zydus acquires two ANDAs from Teva, strengthens its US portfolio
  2. Royal Philips seeks to make one acquisition in India over next one year
  3. Dr Reddy’s to acquire product portfolio of 8 ANDAs from TEVA in the US for USD 350 Mn
  4. Torrent Pharma acquires manufacturing Unit of Glochem for ~USD 45 Mn.
  5. Cancer Genetics Inc. partners with Sayre Therapeutics
  6. Cipla inks pact with Russian firm Nacimbio for antiretroviral drugs
  7. Zydus Cadila and Eczac?ba?? enter into a strategic collaboration to market biosimilars in Turkey
  8. Boston Scientific to make India biggest product development hub outside the US.
  9. India’s BioEconomy crosses $35 billion : ABLE Report

For more such news and updates, please join our Group "Global Life Science Business in India" on LinkedIn.

Aagami Updates:

  1. Aagami completes BIO International Convention 2016 with over 40 promising one to one meetings. 
  2. Aagami completed a highly successful 4 city business trip in India along with a US based plant biotechnology company.
  3. Aagami Inc. and Rosen Biosciences organized an event on 02 June at the Illinois Science + Technology Park, Skokie, Illinois. This event provided an overview of the Indian Pharma and Biotech Market and opportunities for Life science companies based in Illinois.
×
Twitter